← Back to Search

Dronabinol for Postoperative Pain

Phase < 1
Waitlist Available
Led By Diana Martinez, MD
Research Sponsored by New York State Psychiatric Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up two weeks
Awards & highlights

Study Summary

This trial will investigate whether dronabinol can help relieve post-operative pain in patients who have had a total knee replacement.

Eligible Conditions
  • Knee Arthropathy
  • Knee Replacement

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Brief Pain Inventory-Short Form
Secondary outcome measures
opioid medication log

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: dronabinolExperimental Treatment2 Interventions
active group
Group II: controlPlacebo Group2 Interventions
control group
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Dronabinol 5mg Cap
2021
Completed Phase 4
~190

Find a Location

Who is running the clinical trial?

New York State Psychiatric InstituteLead Sponsor
475 Previous Clinical Trials
153,907 Total Patients Enrolled
Diana Martinez, MDPrincipal Investigator - NYSPI
New York State Psychiatric Institute
4 Previous Clinical Trials
66 Total Patients Enrolled

Media Library

Dronabinol 5mg Cap Clinical Trial Eligibility Overview. Trial Name: NCT04099355 — Phase < 1
Knee Replacement Research Study Groups: dronabinol, control
Knee Replacement Clinical Trial 2023: Dronabinol 5mg Cap Highlights & Side Effects. Trial Name: NCT04099355 — Phase < 1
Dronabinol 5mg Cap 2023 Treatment Timeline for Medical Study. Trial Name: NCT04099355 — Phase < 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

In what medical circumstances is Dronabinol 5mg Cap administered?

"Dronabinol 5mg Cap can be an effective pharmaceutical intervention to treat weight loss, a lack of response to traditional treatments, and pharmacotherapy."

Answered by AI

Who is the ideal demographic to recruit for this clinical experiment?

"As part of this research, 80 individuals from the ages of 21 to 65 with joint ailments are being sought. Prerequisites for entry include undergoing total knee arthroplasty at Columbia University Irving Medical Center's orthopedic surgery department as a component of regular care."

Answered by AI

Are there any other investigations exploring the efficacy of 5mg Dronabinol Capsules?

"Currently, 38 studies are running that research the effects of Dronabinol 5mg Cap. Of those active trials, 6 have reached Phase 3. With 90 sites across Belmont, Massachusetts offering clinical trial opportunities for Dronabinol 5mg Cap users."

Answered by AI

Are there any unfilled vacancies in this experiment that participants may apply to?

"This medical study is no longer accepting patients. It was initially posted on September 1st 2030 and the last update occurred on October 11th 2022. For those still looking for clinical trials, 615 studies involving joint illnesses are actively recruiting participants while 38 Dronabinol 5mg Cap related research initiatives are in need of volunteers."

Answered by AI

What is the participant tally for this research endeavor?

"This research endeavor is no longer accepting participants, with its initial posting occurring on September 1st of 2030 and the most recent update taking place in October 11th of 2022. If any other study interests you, 615 trials are recruiting for joint diseases while 38 studies are actively enrolling patients for Dronabinol 5mg Cap."

Answered by AI

Is the age bracket for this experiment restricted to individuals under 85 years old?

"According to the study's eligibility criteria, potential participants must be at least 21 years of age and no older than 65."

Answered by AI
~0 spots leftby Aug 2027